Literature DB >> 3756093

Thalidomide in the treatment of neuro-Behçet's syndrome.

C G Ranselaar, R M Boone, H C Kluin-Nelemans.   

Abstract

No relapses of symptoms in a patient with neuro-Behçet's syndrome were observed after the addition of thalidomide to chlorambucil and prednisolone therapy. At present, the patient has been free of symptoms for 3 years. This observation, together with those reported from the literature, strongly support a re-evaluation of thalidomide therapy in certain life-threatening diseases such as neuro-Behçet's syndrome.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3756093     DOI： 10.1111/j.1365-2133.1986.tb05753.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


  4 in total

1.  A rare manifestation of Behçet's syndrome: immunological correlates and successful treatment of an esophageal ulcer.

Authors:  Heiner Wedemeyer; Jens G Kuipers; Konrad Streetz; Michael Mengel; Ingolf Schedel; Nikolina Kezmic; Peter Meier; Henning Zeidler; Michael P Manns; Siegfried Wagner
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

Review 2.  Neuro-Behçet's syndrome: differential diagnosis and management.

Authors:  Erdal Diri; Louis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

Review 3.  Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations.

Authors:  V Günzler
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

4.  The effect of thalidomide and supidimide on endotoxin-induced uveitis in rats.

Authors:  Y Guex-Crosier; N Pittet; C P Herbort
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-02       Impact factor: 3.117
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.